AMPEL BioSolutions
Pre-clinicalUses computational biology and AI to develop precision medicine approaches for autoimmune and inflammatory diseases.
Founded
2014
Focus
AI / Machine LearningImmunologyRare Disease
About
Uses computational biology and AI to develop precision medicine approaches for autoimmune and inflammatory diseases.
Funding History
2Total raised: $3M
Seed$2.5MUndisclosedJun 15, 2020
Grant$500KNational Institutes of HealthJun 15, 2018
Company Info
TypePrivate
Founded2014
LocationCharlottesville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile